Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatocyte growth factor activator inhibitor type-1 in cancer: Advances and perspectives (Review)

13 Oct 2014

Abstract excerpt

Cancer is one of the most common diseases, with high morbidity and mortality rates. Large‑scale efforts have been made to understand the pathogenesis of the disease, particularly in the advanced stages, in order to develop effective therapeutic approaches. Hepatocyte growth factor activator inhibitor type-1 (HAI-1), also known as serine protease inhibitor Kunitz type 1, inhibits the activity of several...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Drug Transport and Resistance Mechanisms
Share to Liver physiology and pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25310042
DOI: 10.3892/mmr.2014.2628

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatocyte growth factor activator inhibitor type-1 in cancer: Advances and perspectives (Review)PMID 25310042Read ↗

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.Semantic proximity Read ↗

Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.Semantic proximity Read ↗

[Status quo of research on HGFc-Met signaling pathway in cancers].Semantic proximity Read ↗

HGF/c-MET Axis in Tumor Microenvironment and Metastasis FormationSemantic proximity Read ↗

HGFAC expression decreased in liver cancer and its low expression correlated with DNA hypermethylation and poor prognosisSemantic proximity Read ↗

Targeting the c-Met Signaling Pathway in CancerSemantic proximity Read ↗

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunitiesSemantic proximity Read ↗

Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) Is Required for Branching Morphogenesis in the Chorioallantoic PlacentaSemantic proximity Read ↗

HGF/c-MET pathway in cancer: from molecular characterization to clinical evidenceSemantic proximity Read ↗

The impact of hepatocyte nuclear factor-1α on liver malignancies and cell stemness with metabolic consequences.Semantic proximity Read ↗

Targeting mesenchymal-epithelial transition factor signaling in cancer: from genetic alterations to clinical advances and future prospects.Semantic proximity Read ↗

Purification and Cloning of Hepatocyte Growth Factor Activator Inhibitor Type 2, a Kunitz-type Serine Protease InhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.